- Diclofenac Sodium BP : 25.0 mg
- BenzyleAlcohol BP: 4.0% v/v/v
- Water for injection BP: q.s
- Packaging Type: Glass Bottle
Lekalza Injection is indicated for the treatment of the signs and symptoms of acute and chronic rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. Painful post-traumatic and post-operative inflammation and swelling. pain following dental surgery. Acute attacks of gout. Painful gynecological conditions.Dosage and direction for use :
The recommended doses of the diclofenac injection is 1 ampoule (75 mg) once daily or, if required in severe cases twice daily, injected deep intraglutealy.
Diclofenac injection for intramuscular and should not be mixed with other injection sole Lekalza Injection should not be given more than 2 days.Lekalza Injection are not recommended for use in children.
OR As directed by the physicianContraindications :
Lekalza injections are contraindicated in the patient who is hypersensitive to it, and in whom drugs like and other NSAIDs precipitate attacks of asthma, urticaria or acute rheumatic. It should be given to patients with peptic ulcer.Side effects :
Perforation of gastriculcers.
GIT haemorrhage, blood dyscriasias and anaphylaxis (rare)
Others: G.I. disturbances, headache, dizziness. rash, pruritus, peripheral oedema.
G.I.Bleeding: Pepticulcer, abnormalities of liver and kidney function.Drug Interaction :
Deterioration in renal function has been attributed to the concomitant use of Diclofenac and triamterene or cyclosporin. As with other NSAIDs, Diclofenac Sodium is likely to inhibit the activity of the diuretics. Concomitant treatment with potassium diuretics may increase the serum potassium levels. Plasma concentrations of lithium or digoxin are increased when these drugs are given together with Diclofenac Sodium.